Building Blocks
Subcategories of "Building Blocks"
- Boronic Acids & Boronic Acid Derivatives(5,780 products)
- Chiral Building Blocks(1,241 products)
- Hydrocarbon Building Blocks(6,100 products)
- Organic Building Blocks(61,029 products)
Found 205306 products of "Building Blocks"
(2,2-Dimethylcyclopropyl)methanamine hydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H14ClNPurity:Min. 95%Molecular weight:135.63 g/mol6-(aminomethyl)pyridin-3-amine dihydrochloride
CAS:Versatile small molecule scaffoldFormula:C6H11Cl2N3Purity:Min. 95%Molecular weight:196.08 g/mol1-(4,6-Dimethylpyrimidin-2-yl)-5-methyl-1H-pyrazole-3-carboxylic acid
CAS:Versatile small molecule scaffold
Formula:C11H12N4O2Purity:Min. 95%Molecular weight:232.24 g/mol6-Bromo-3-methylthieno[3,2-b]thiophene-2-carboxylic acid
CAS:6-Bromo-3-methylthieno[3,2-b]thiophene-2-carboxylic acid (MTTC) is a synthetic drug that is used to treat gastrointestinal inflammation and metabolic disorders. MTTC has been shown to interact with other drugs, such as the potential interaction of MTTC with omeprazole or the interaction of MTTC with an oral contraceptive. The effects of MTTC on patients with autoimmune diseases are not well understood. There have been reports of liver damage and bowel disease in some patients. Patients should be monitored for any signs of bowel disease, lipid levels, and liver function during treatment with this drug. br>br> In vivo studies have found that MTTC stimulates the production of prostaglandins and leukotrienes in colonic epithelial cells by inhibiting cyclooxygenase enzymes COX1 and COX2. This action can lead to oxidative stress, which may contribute toFormula:C8H5BrO2S2Purity:Min. 95%Molecular weight:277.2 g/mol2-Oxo-2,3-dihydro-1,3-benzoxazole-7-carbaldehyde
CAS:Versatile small molecule scaffoldFormula:C8H5NO3Purity:Min. 95%Molecular weight:163.13 g/mol4-(Imidazo[1,2-a]pyridin-2-ylmethoxy)benzoic acid
CAS:4-(Imidazo[1,2-a]pyridin-2-ylmethoxy)benzoic acid is a white crystalline compound. It is an impurity in the drug product, 4-(Imidazo[1,2-a]pyridin-2-ylmethoxy)benzoic acid hydrochloride. This impurity has been shown to be a natural component of the API. It has also been synthesized for research and development purposes. The CAS number for this compound is 301860-84-4.Formula:C15H12N2O3Purity:Min. 95%Molecular weight:268.27 g/mol4-[(4-Chlorophenyl)thio]-3,5-dimethyl-1H-pyrazole
CAS:Versatile small molecule scaffold
Formula:C11H11ClN2SPurity:Min. 95%Molecular weight:238.74 g/mol3-(2-Aminoethyl)-5-[(4-fluorophenyl)methylidene]-1,3-thiazolidine-2,4-dione hydrochloride
CAS:Versatile small molecule scaffoldFormula:C12H12ClFN2O2SPurity:Min. 95%Molecular weight:302.75 g/mol2-(2,3-Dioxo-2,3-dihydro-1H-indol-1-yl)-N-(3-methylphenyl)acetamide
CAS:Versatile small molecule scaffoldFormula:C17H14N2O3Purity:Min. 95%Molecular weight:294.3 g/molN-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide
CAS:N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide is a nonsteroidal compound that inhibits the activity of certain kinases involved in the inflammatory response. It has been shown to reduce inflammation and modulate immune responses, as well as regulate immune cells. N-(1H-benzo[d]imidazol-2-yl)-3-nitrobenzamide also has a regulatory effect on nitrogen metabolism and participates in the regulation of cell proliferation. This drug may be useful for treating diseases related to immunology, such as chronic obstructive pulmonary disease or arthritis.Formula:C14H10N4O3Purity:Min. 95%Molecular weight:282.25 g/molethyl 3-(cyanomethyl)pyridine-2-carboxylate
CAS:Versatile small molecule scaffoldFormula:C10H10N2O2Purity:Min. 95%Molecular weight:190.2 g/mol4-Methyl-2-(tributylstannyl)pyridine
CAS:Controlled ProductVersatile small molecule scaffoldFormula:C18H33NSnPurity:Min. 95%Molecular weight:382.18 g/mol({[3-(4-Bromophenyl)-1-phenyl-1H-pyrazol-4-yl]methyl}sulfanyl)methanimidamide hydrochloride
CAS:Versatile small molecule scaffoldFormula:C17H16BrClN4SPurity:Min. 95%Molecular weight:423.8 g/mol(3-Isocyanatopropoxy)benzene
CAS:Versatile small molecule scaffoldFormula:C10H11NO2Purity:Min. 95%Molecular weight:177.2 g/mol2-Amino-N-benzyl-5-hydroxybenzamide
CAS:Versatile small molecule scaffoldFormula:C14H14N2O2Purity:Min. 95%Molecular weight:242.27 g/mol4-(2-bromophenyl)-1H-pyrazol-5-amine
CAS:Versatile small molecule scaffoldFormula:C9H8BrN3Purity:Min. 95%Molecular weight:238.1 g/molEthyl [(2-methyl-5-nitrophenyl)carbamoyl]formate
CAS:Versatile small molecule scaffoldFormula:C11H12N2O5Purity:Min. 95%Molecular weight:252.22 g/mol2-(2,3-Dihydro-1H-1,3-benzodiazol-2-ylidene)-3-oxobutanenitrile
CAS:Versatile small molecule scaffoldFormula:C11H9N3OPurity:Min. 95%Molecular weight:199.21 g/mol3-Azetidinyl phenyl ether hydrochloride
CAS:Versatile small molecule scaffoldFormula:C9H12ClNOPurity:Min. 95%Molecular weight:185.66 g/mol2-Ethyl-2-(3-methoxyphenyl)pyrrolidine
CAS:Versatile small molecule scaffoldFormula:C13H19NOPurity:Min. 95%Molecular weight:205.3 g/molImidazo[1,2-a]pyrimidin-2-amine
CAS:Versatile small molecule scaffoldFormula:C6H6N4Purity:Min. 95%Molecular weight:134.14 g/mol1-[(2-Nitrophenyl)sulfonyl]piperazine
CAS:1-[(2-Nitrophenyl)sulfonyl]piperazine (1-NPSP) is a novel acetylcholine receptor antagonist that can be synthesized. It has been shown to have an addictive potential and has been used in animal models for this purpose. 1-NPSP also inhibits the synthesis of amines, and has been shown to have cytotoxic effects on certain types of cancer cells.Formula:C10H13N3O4SPurity:Min. 95%Molecular weight:271.29 g/mol4-Chloro-N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-3-nitrobenzene-1-sulfonamide
CAS:Versatile small molecule scaffoldFormula:C17H15ClN4O5SPurity:Min. 95%Molecular weight:422.8 g/mol3,4-Dihydro[1,2,4]thiadiazino[3,4-b][1,3]benzothiazole-8-carboxylic acid 2,2-dioxide
CAS:Versatile small molecule scaffoldFormula:C10H8N2O4S2Purity:Min. 95%Molecular weight:284.3 g/mol2-Chloro-N-{5-[(2-chlorophenyl)methyl]-1,3-thiazol-2-yl}acetamide
CAS:Versatile small molecule scaffold
Formula:C12H10Cl2N2OSPurity:Min. 95%Molecular weight:301.2 g/molN-(5-Benzyl-1,3-thiazol-2-yl)-2-chloroacetamide
CAS:Versatile small molecule scaffoldFormula:C12H11ClN2OSPurity:Min. 95%Molecular weight:266.75 g/molFlt-3 Inhibitor
CAS:Flt-3 inhibitors are a class of drugs that inhibit the tyrosine kinase activity of the Flt-3 receptor. This receptor is overexpressed in many cancers and its inhibition has been shown to induce apoptosis in cancer cells. The anti-leukemic activity of flt-3 inhibitors has been demonstrated in animal models and clinical studies have shown potent inhibitory activity against leukemia cells. In addition, this drug has been shown to be effective against epithelial cancers such as breast cancer and colon cancer. Flt-3 inhibitors have also been shown to inhibit tumor growth in animal models by blocking the production of vascular endothelial growth factor (VEGF).
Formula:C18H20N2O4SPurity:Min. 95%Molecular weight:360.43 g/mol5-(2,3-Dihydro-1,4-benzodioxin-6-yl)-5-methylimidazolidine-2,4-dione
CAS:Versatile small molecule scaffold
Formula:C12H12N2O4Purity:Min. 95%Molecular weight:248.23 g/mol5-Phenyl-3-(prop-2-en-1-yl)-2-sulfanyl-3H,4H-thieno[2,3-d]pyrimidin-4-one
CAS:Versatile small molecule scaffoldFormula:C15H12N2OS2Purity:Min. 95%Molecular weight:300.4 g/mol6-Methoxy-2-(trifluoromethyl)-1,4-dihydroquinazolin-4-one
CAS:Versatile small molecule scaffold
Formula:C10H7F3N2O2Purity:Min. 95%Molecular weight:244.17 g/molN-(3,4-Dimethylphenyl)-1,1-dioxo-2,3-dihydrothiophen-3-amine
CAS:Versatile small molecule scaffoldFormula:C12H15NO2SPurity:Min. 95%Molecular weight:237.32 g/molN-[2-(1H-1,3-Benzodiazol-2-yl)ethyl]propanamide
CAS:Versatile small molecule scaffoldFormula:C12H15N3OPurity:Min. 95%Molecular weight:217.27 g/moltert-Butyl 4-[(pyridin-3-yl)amino]piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C15H23N3O2Purity:Min. 95%Molecular weight:277.36 g/mol3-(Piperidin-4-yl)pyridine dihydrochloride
CAS:3-(Piperidin-4-yl)pyridine dihydrochloride (3PP) is a natural compound that has been identified as a novel inhibitor of the mitochondrial membrane potential. 3PP is also an anion radical scavenger, which could be responsible for its protective effects against oxidative stress in cells. 3PP has been shown to inhibit the tumor growth and inhibit locomotor activity in mice. The drug also inhibits the production of proinflammatory cytokines and induces anti-inflammatory cytokines. In addition, it has been found to have inhibitory properties on MCL-1 protein, which is a key regulator of apoptosis.Formula:C10H16Cl2N2Purity:Min. 95%Molecular weight:235.15 g/moltert-Butyl 4-(2-bromoacetyl)piperidine-1-carboxylate
CAS:Versatile small molecule scaffold
Formula:C12H20BrNO3Purity:Min. 95%Molecular weight:306.2 g/moltert-Butyl 4-(1-bromo-2-oxoethyl)piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C12H20BrNO3Purity:Min. 95%Molecular weight:306.2 g/mol2-(Azidomethyl)imidazo[1,2-a]pyrimidine
CAS:Versatile small molecule scaffoldFormula:C7H6N6Purity:Min. 95%Molecular weight:174.16 g/moltert-Butyl 4-(prop-2-yn-1-yl)piperidine-1-carboxylate
CAS:Versatile small molecule scaffoldFormula:C13H21NO2Purity:Min. 95%Molecular weight:223.31 g/mol2-{[(2-Methylphenyl)carbamoyl]methyl}benzoic acid
CAS:Versatile small molecule scaffoldFormula:C16H15NO3Purity:Min. 95%Molecular weight:269.29 g/moltert-Butyl 3-(iodomethyl)benzoate
CAS:Versatile small molecule scaffoldFormula:C12H15IO2Purity:Min. 95%Molecular weight:318.2 g/moltert-Butyl 1H-1,2,4-triazole-3-carboxylate
CAS:Versatile small molecule scaffoldFormula:C7H11N3O2Purity:Min. 95%Molecular weight:169.18 g/mol1-[(tert-Butoxy)carbonyl]-4-[(prop-2-en-1-yloxy)methyl]piperidine-4-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C15H25NO5Purity:Min. 95%Molecular weight:299.4 g/molMethyl 3-(isobutylamino)-2,2-dimethylpropanoate
CAS:Versatile small molecule scaffold
Formula:C10H21NO2Purity:Min. 95%Molecular weight:187.28 g/mol4-[(Dimethylamino)methyl]-3-methoxyaniline
CAS:Versatile small molecule scaffoldFormula:C10H16N2OPurity:Min. 95%Molecular weight:180.25 g/mol8-Bromo-4-chloro-7-methylquinoline-3-carbonitrile
CAS:Versatile small molecule scaffoldFormula:C11H6BrClN2Purity:Min. 95%Molecular weight:281.53 g/mol4-Methyl-2-[(pyrrolidin-3-yloxy)methyl]-1,3-thiazole
CAS:Versatile small molecule scaffoldFormula:C9H14N2OSPurity:Min. 95%Molecular weight:198.29 g/mol2-(Hydroxymethyl)-4-methyl-1,3-thiazole-5-carboxylic acid
CAS:Versatile small molecule scaffoldFormula:C6H7NO3SPurity:Min. 95%Molecular weight:173.2 g/mol2-{5H,6H,8H-[1,2,4]Triazolo[3,4-c][1,4]oxazin-3-yl}ethan-1-ol
CAS:Versatile small molecule scaffoldFormula:C7H11N3O2Purity:Min. 95%Molecular weight:169.18 g/mol5-(Bromomethyl)-3-(1,5-dimethyl-1H-pyrazol-4-yl)-1,2-oxazole
CAS:Versatile small molecule scaffoldFormula:C9H10BrN3OPurity:Min. 95%Molecular weight:256.1 g/mol1-(2-Cyclopropyl-1H-1,3-benzodiazol-5-yl)ethan-1-amine
CAS:Versatile small molecule scaffoldFormula:C12H15N3Purity:Min. 95%Molecular weight:201.27 g/mol
